Global Hemophilia A Drug Market Growth 2022-2028

Global Hemophilia A Drug Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemophilia A Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hemophilia A Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hemophilia A Drug by Country/Region, 2017, 2022 & 2028
2.2 Hemophilia A Drug Segment by Type
2.2.1 ATXF-8117
2.2.2 BAY-1093884
2.2.3 BIVV-001
2.2.4 BS-027125
2.2.5 Concizumab
2.2.6 CSL-689
2.2.7 Others
2.3 Hemophilia A Drug Sales by Type
2.3.1 Global Hemophilia A Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Hemophilia A Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hemophilia A Drug Sale Price by Type (2017-2022)
2.4 Hemophilia A Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 ASCs
2.5 Hemophilia A Drug Sales by Application
2.5.1 Global Hemophilia A Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Hemophilia A Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hemophilia A Drug Sale Price by Application (2017-2022)
3 Global Hemophilia A Drug by Company
3.1 Global Hemophilia A Drug Breakdown Data by Company
3.1.1 Global Hemophilia A Drug Annual Sales by Company (2020-2022)
3.1.2 Global Hemophilia A Drug Sales Market Share by Company (2020-2022)
3.2 Global Hemophilia A Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Hemophilia A Drug Revenue by Company (2020-2022)
3.2.2 Global Hemophilia A Drug Revenue Market Share by Company (2020-2022)
3.3 Global Hemophilia A Drug Sale Price by Company
3.4 Key Manufacturers Hemophilia A Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemophilia A Drug Product Location Distribution
3.4.2 Players Hemophilia A Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hemophilia A Drug by Geographic Region
4.1 World Historic Hemophilia A Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Hemophilia A Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hemophilia A Drug Annual Revenue by Geographic Region
4.2 World Historic Hemophilia A Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Hemophilia A Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hemophilia A Drug Annual Revenue by Country/Region
4.3 Americas Hemophilia A Drug Sales Growth
4.4 APAC Hemophilia A Drug Sales Growth
4.5 Europe Hemophilia A Drug Sales Growth
4.6 Middle East & Africa Hemophilia A Drug Sales Growth
5 Americas
5.1 Americas Hemophilia A Drug Sales by Country
5.1.1 Americas Hemophilia A Drug Sales by Country (2017-2022)
5.1.2 Americas Hemophilia A Drug Revenue by Country (2017-2022)
5.2 Americas Hemophilia A Drug Sales by Type
5.3 Americas Hemophilia A Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemophilia A Drug Sales by Region
6.1.1 APAC Hemophilia A Drug Sales by Region (2017-2022)
6.1.2 APAC Hemophilia A Drug Revenue by Region (2017-2022)
6.2 APAC Hemophilia A Drug Sales by Type
6.3 APAC Hemophilia A Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hemophilia A Drug by Country
7.1.1 Europe Hemophilia A Drug Sales by Country (2017-2022)
7.1.2 Europe Hemophilia A Drug Revenue by Country (2017-2022)
7.2 Europe Hemophilia A Drug Sales by Type
7.3 Europe Hemophilia A Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemophilia A Drug by Country
8.1.1 Middle East & Africa Hemophilia A Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hemophilia A Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Hemophilia A Drug Sales by Type
8.3 Middle East & Africa Hemophilia A Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemophilia A Drug
10.3 Manufacturing Process Analysis of Hemophilia A Drug
10.4 Industry Chain Structure of Hemophilia A Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemophilia A Drug Distributors
11.3 Hemophilia A Drug Customer
12 World Forecast Review for Hemophilia A Drug by Geographic Region
12.1 Global Hemophilia A Drug Market Size Forecast by Region
12.1.1 Global Hemophilia A Drug Forecast by Region (2023-2028)
12.1.2 Global Hemophilia A Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hemophilia A Drug Forecast by Type
12.7 Global Hemophilia A Drug Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Hemophilia A Drug Product Offered
13.1.3 Bayer AG Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 BioMarin Pharmaceutical Inc
13.2.1 BioMarin Pharmaceutical Inc Company Information
13.2.2 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Offered
13.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BioMarin Pharmaceutical Inc Main Business Overview
13.2.5 BioMarin Pharmaceutical Inc Latest Developments
13.3 Bioverativ Inc
13.3.1 Bioverativ Inc Company Information
13.3.2 Bioverativ Inc Hemophilia A Drug Product Offered
13.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bioverativ Inc Main Business Overview
13.3.5 Bioverativ Inc Latest Developments
13.4 Catalyst Biosciences Inc
13.4.1 Catalyst Biosciences Inc Company Information
13.4.2 Catalyst Biosciences Inc Hemophilia A Drug Product Offered
13.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Catalyst Biosciences Inc Main Business Overview
13.4.5 Catalyst Biosciences Inc Latest Developments
13.5 Chugai Pharmaceutical Co Ltd
13.5.1 Chugai Pharmaceutical Co Ltd Company Information
13.5.2 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Offered
13.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chugai Pharmaceutical Co Ltd Main Business Overview
13.5.5 Chugai Pharmaceutical Co Ltd Latest Developments
13.6 CSL Ltd
13.6.1 CSL Ltd Company Information
13.6.2 CSL Ltd Hemophilia A Drug Product Offered
13.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CSL Ltd Main Business Overview
13.6.5 CSL Ltd Latest Developments
13.7 DBV Technologies SA
13.7.1 DBV Technologies SA Company Information
13.7.2 DBV Technologies SA Hemophilia A Drug Product Offered
13.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 DBV Technologies SA Main Business Overview
13.7.5 DBV Technologies SA Latest Developments
13.8 Dimension Therapeutics Inc
13.8.1 Dimension Therapeutics Inc Company Information
13.8.2 Dimension Therapeutics Inc Hemophilia A Drug Product Offered
13.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dimension Therapeutics Inc Main Business Overview
13.8.5 Dimension Therapeutics Inc Latest Developments
13.9 EpiVax Inc
13.9.1 EpiVax Inc Company Information
13.9.2 EpiVax Inc Hemophilia A Drug Product Offered
13.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 EpiVax Inc Main Business Overview
13.9.5 EpiVax Inc Latest Developments
13.10 Expression Therapeutics LLC
13.10.1 Expression Therapeutics LLC Company Information
13.10.2 Expression Therapeutics LLC Hemophilia A Drug Product Offered
13.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Expression Therapeutics LLC Main Business Overview
13.10.5 Expression Therapeutics LLC Latest Developments
13.11 Green Cross Corp
13.11.1 Green Cross Corp Company Information
13.11.2 Green Cross Corp Hemophilia A Drug Product Offered
13.11.3 Green Cross Corp Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Green Cross Corp Main Business Overview
13.11.5 Green Cross Corp Latest Developments
13.12 Idogen AB
13.12.1 Idogen AB Company Information
13.12.2 Idogen AB Hemophilia A Drug Product Offered
13.12.3 Idogen AB Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Idogen AB Main Business Overview
13.12.5 Idogen AB Latest Developments
13.13 Immusoft Corp
13.13.1 Immusoft Corp Company Information
13.13.2 Immusoft Corp Hemophilia A Drug Product Offered
13.13.3 Immusoft Corp Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Immusoft Corp Main Business Overview
13.13.5 Immusoft Corp Latest Developments
13.14 LFB SA
13.14.1 LFB SA Company Information
13.14.2 LFB SA Hemophilia A Drug Product Offered
13.14.3 LFB SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 LFB SA Main Business Overview
13.14.5 LFB SA Latest Developments
13.15 mAbxience SA
13.15.1 mAbxience SA Company Information
13.15.2 mAbxience SA Hemophilia A Drug Product Offered
13.15.3 mAbxience SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 mAbxience SA Main Business Overview
13.15.5 mAbxience SA Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hemophilia A Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hemophilia A Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ATXF-8117
Table 4. Major Players of BAY-1093884
Table 5. Major Players of BIVV-001
Table 6. Major Players of BS-027125
Table 7. Major Players of Concizumab
Table 8. Major Players of CSL-689
Table 9. Major Players of Others
Table 10. Global Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Hemophilia A Drug Sales Market Share by Type (2017-2022)
Table 12. Global Hemophilia A Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Hemophilia A Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Hemophilia A Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Hemophilia A Drug Sales Market Share by Application (2017-2022)
Table 17. Global Hemophilia A Drug Revenue by Application (2017-2022)
Table 18. Global Hemophilia A Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Hemophilia A Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Hemophilia A Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Hemophilia A Drug Sales Market Share by Company (2020-2022)
Table 22. Global Hemophilia A Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Hemophilia A Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Hemophilia A Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Hemophilia A Drug Producing Area Distribution and Sales Area
Table 26. Players Hemophilia A Drug Products Offered
Table 27. Hemophilia A Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Hemophilia A Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Hemophilia A Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Hemophilia A Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Hemophilia A Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Hemophilia A Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Hemophilia A Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Hemophilia A Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Hemophilia A Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Hemophilia A Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Hemophilia A Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Hemophilia A Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Hemophilia A Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Hemophilia A Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Hemophilia A Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Hemophilia A Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Hemophilia A Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Hemophilia A Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Hemophilia A Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Hemophilia A Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Hemophilia A Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Hemophilia A Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Hemophilia A Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Hemophilia A Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Hemophilia A Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Hemophilia A Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Hemophilia A Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Hemophilia A Drug
Table 71. Key Market Challenges & Risks of Hemophilia A Drug
Table 72. Key Industry Trends of Hemophilia A Drug
Table 73. Hemophilia A Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Hemophilia A Drug Distributors List
Table 76. Hemophilia A Drug Customer List
Table 77. Global Hemophilia A Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Hemophilia A Drug Sales Market Forecast by Region
Table 79. Global Hemophilia A Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Hemophilia A Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Hemophilia A Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Hemophilia A Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Hemophilia A Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Hemophilia A Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Hemophilia A Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Hemophilia A Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Hemophilia A Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Hemophilia A Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Hemophilia A Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Hemophilia A Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. Bayer AG Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer AG Hemophilia A Drug Product Offered
Table 99. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Bayer AG Main Business
Table 101. Bayer AG Latest Developments
Table 102. BioMarin Pharmaceutical Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. BioMarin Pharmaceutical Inc Hemophilia A Drug Product Offered
Table 104. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. BioMarin Pharmaceutical Inc Main Business
Table 106. BioMarin Pharmaceutical Inc Latest Developments
Table 107. Bioverativ Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Bioverativ Inc Hemophilia A Drug Product Offered
Table 109. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Bioverativ Inc Main Business
Table 111. Bioverativ Inc Latest Developments
Table 112. Catalyst Biosciences Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Catalyst Biosciences Inc Hemophilia A Drug Product Offered
Table 114. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Catalyst Biosciences Inc Main Business
Table 116. Catalyst Biosciences Inc Latest Developments
Table 117. Chugai Pharmaceutical Co Ltd Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Offered
Table 119. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Chugai Pharmaceutical Co Ltd Main Business
Table 121. Chugai Pharmaceutical Co Ltd Latest Developments
Table 122. CSL Ltd Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. CSL Ltd Hemophilia A Drug Product Offered
Table 124. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. CSL Ltd Main Business
Table 126. CSL Ltd Latest Developments
Table 127. DBV Technologies SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. DBV Technologies SA Hemophilia A Drug Product Offered
Table 129. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. DBV Technologies SA Main Business
Table 131. DBV Technologies SA Latest Developments
Table 132. Dimension Therapeutics Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Dimension Therapeutics Inc Hemophilia A Drug Product Offered
Table 134. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Dimension Therapeutics Inc Main Business
Table 136. Dimension Therapeutics Inc Latest Developments
Table 137. EpiVax Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. EpiVax Inc Hemophilia A Drug Product Offered
Table 139. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. EpiVax Inc Main Business
Table 141. EpiVax Inc Latest Developments
Table 142. Expression Therapeutics LLC Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Expression Therapeutics LLC Hemophilia A Drug Product Offered
Table 144. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Expression Therapeutics LLC Main Business
Table 146. Expression Therapeutics LLC Latest Developments
Table 147. Green Cross Corp Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Green Cross Corp Hemophilia A Drug Product Offered
Table 149. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Green Cross Corp Main Business
Table 151. Green Cross Corp Latest Developments
Table 152. Idogen AB Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Idogen AB Hemophilia A Drug Product Offered
Table 154. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Idogen AB Main Business
Table 156. Idogen AB Latest Developments
Table 157. Immusoft Corp Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Immusoft Corp Hemophilia A Drug Product Offered
Table 159. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Immusoft Corp Main Business
Table 161. Immusoft Corp Latest Developments
Table 162. LFB SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. LFB SA Hemophilia A Drug Product Offered
Table 164. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. LFB SA Main Business
Table 166. LFB SA Latest Developments
Table 167. mAbxience SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. mAbxience SA Hemophilia A Drug Product Offered
Table 169. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. mAbxience SA Main Business
Table 171. mAbxience SA Latest Developments
List of Figures
Figure 1. Picture of Hemophilia A Drug
Figure 2. Hemophilia A Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemophilia A Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Hemophilia A Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hemophilia A Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ATXF-8117
Figure 10. Product Picture of BAY-1093884
Figure 11. Product Picture of BIVV-001
Figure 12. Product Picture of BS-027125
Figure 13. Product Picture of Concizumab
Figure 14. Product Picture of CSL-689
Figure 15. Product Picture of Others
Figure 16. Global Hemophilia A Drug Sales Market Share by Type in 2021
Figure 17. Global Hemophilia A Drug Revenue Market Share by Type (2017-2022)
Figure 18. Hemophilia A Drug Consumed in Clinic
Figure 19. Global Hemophilia A Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 20. Hemophilia A Drug Consumed in Hospital
Figure 21. Global Hemophilia A Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 22. Hemophilia A Drug Consumed in ASCs
Figure 23. Global Hemophilia A Drug Market: ASCs (2017-2022) & (K Pcs)
Figure 24. Global Hemophilia A Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Hemophilia A Drug Revenue Market Share by Application in 2021
Figure 26. Hemophilia A Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Hemophilia A Drug Revenue Market Share by Company in 2021
Figure 28. Global Hemophilia A Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Hemophilia A Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Hemophilia A Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Hemophilia A Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Hemophilia A Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Hemophilia A Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Hemophilia A Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Hemophilia A Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Hemophilia A Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Hemophilia A Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Hemophilia A Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Hemophilia A Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Hemophilia A Drug Sales Market Share by Country in 2021
Figure 41. Americas Hemophilia A Drug Revenue Market Share by Country in 2021
Figure 42. United States Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Hemophilia A Drug Sales Market Share by Region in 2021
Figure 47. APAC Hemophilia A Drug Revenue Market Share by Regions in 2021
Figure 48. China Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Hemophilia A Drug Sales Market Share by Country in 2021
Figure 55. Europe Hemophilia A Drug Revenue Market Share by Country in 2021
Figure 56. Germany Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Hemophilia A Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Hemophilia A Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Hemophilia A Drug in 2021
Figure 69. Manufacturing Process Analysis of Hemophilia A Drug
Figure 70. Industry Chain Structure of Hemophilia A Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs